BlackRock’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.8K | Sell |
7,421
-1,357
| -15% | -$10K | ﹤0.01% | 4900 |
|
|
2025
Q1 | $75.8K | Sell |
8,778
-50
| -0.6% | -$432 | ﹤0.01% | 4781 |
|
|
2024
Q4 | $61.5K | Buy |
8,828
+15
| +0.2% | +$105 | ﹤0.01% | 4841 |
|
|
2024
Q3 | $66.1K | Buy |
8,813
+93
| +1% | +$697 | ﹤0.01% | 4698 |
|
|
2024
Q2 | $82.8K | Buy |
8,720
+1,105
| +15% | +$10.5K | ﹤0.01% | 4696 |
|
|
2024
Q1 | $69.2K | Sell |
7,615
-31
| -0.4% | -$282 | ﹤0.01% | 4750 |
|
|
2023
Q4 | $81.8K | Sell |
7,646
-404
| -5% | -$4.32K | ﹤0.01% | 4789 |
|
|
2023
Q3 | $88.5K | Sell |
8,050
-153
| -2% | -$1.68K | ﹤0.01% | 4812 |
|
|
2023
Q2 | $172K | Buy |
8,203
+7,117
| +655% | +$149K | ﹤0.01% | 4685 |
|
|
2023
Q1 | $20.6K | Buy |
1,086
+36
| +3% | +$682 | ﹤0.01% | 5170 |
|
|
2022
Q4 | $27.4K | Buy |
1,050
+49
| +5% | +$1.28K | ﹤0.01% | 5258 |
|
|
2022
Q3 | $21K | Buy |
1,001
+337
| +51% | +$7.07K | ﹤0.01% | 5413 |
|
|
2022
Q2 | $10K | Sell |
664
-1,100
| -62% | -$16.6K | ﹤0.01% | 5532 |
|
|
2022
Q1 | $40K | Buy |
1,764
+724
| +70% | +$16.4K | ﹤0.01% | 5369 |
|
|
2021
Q4 | $46K | Buy |
+1,040
| New | +$46K | ﹤0.01% | 5343 |
|